Suraksha Diagnostic Dividend History
- Market cap
- ₹1,625 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹224.68 – ₹421.27
Suraksha Diagnostic last went ex-dividend on 11 June 2026 for ₹6.50 per share. Over the past 12 months it paid ₹6.50 per share, a trailing yield of 1.20% at the latest close of ₹312.05.
Dividend summary
- Dividends with ex-date in last 12 months
- ₹6.50 per share
- Trailing dividend yield
- 1.20%
Suraksha Diagnostic dividends, bonus issues and splits
Newest first, as announced on BSE.
| Ex-date | Action | Amount / ratio | Record date | Details |
|---|---|---|---|---|
| 11 Jun 2026 | Dividend | ₹6.50/share | 13 Jun 2026 | Final Dividend |
Source: Corporate actions announced on BSE. Data as of 9 October 2026. How this data is compiled.
Suraksha Diagnostic dividend history — frequently asked questions
Does Suraksha Diagnostic pay a dividend?
Yes. Suraksha Diagnostic has gone ex-dividend 1 time in the period shown, most recently on 11 June 2026 (₹6.50 per share).
What is the dividend yield of Suraksha Diagnostic?
Based on dividends with an ex-date in the last 12 months (₹6.50 per share) and the latest close of ₹312.05, Suraksha Diagnostic's trailing dividend yield is 1.20%.
Has Suraksha Diagnostic issued bonus shares or split its stock?
No bonus issue or stock split is recorded for Suraksha Diagnostic in the last ten years.
Same Data For Peers
- Suven Life Sciences Limited dividend history
- Supriya Lifescience Limited dividend history
- Syncom Formulations (India) Limited dividend history
- Supreme Holdings & Hospitality (India) Limited dividend history
- Syngene International Limited dividend history
- Sun Pharmaceutical Industries Limited dividend history
Trade Suraksha Diagnostic With ATS
Track SURAKSHA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.